Current Hematologic Malignancy Reports: Impact Factor, Indexing, Publication Time & Fees


The Current Hematologic Malignancy Reports is reputed journal publishes research related to Hematology (Q1); Cancer Research (Q2); Oncology (Q2). The ISSN of the journal is .

Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.

Current Hematologic Malignancy Reports: Details

Journal TitleCurrent Hematologic Malignancy Reports
PublisherSpringer
Publication CountryUnited States
ISSN15588211, 1558822X
Publication AreaBiochemistry, Genetics and Molecular Biology; Medicine
Publication LanguageENG
Review Process
Scopus IndexedYes

Current Hematologic Malignancy Reports Impact Factor

The Impact Factor of Current Hematologic Malignancy Reports in 2026 is 4.0.

Journal Quartile

The Current Hematologic Malignancy Reports is ranked in Q2.

Indexing

The Current Hematologic Malignancy Reports is indexed in: Web of Science.



Similiar journals to publish


Current Hematologic Malignancy Reports
ISSN:
Publisher: Springer
Journal Scope: Hematology (Q1); Cancer Research (Q2); Oncology (Q2)

Hematologic Malignancies
ISSN: 21979766
Publisher: Springer Science and Business Media Deutschland GmbH
Journal Scope:

Hematologic Pathology
ISSN: 8860238
Publisher: Marcel Dekker Inc.
Journal Scope:

International Journal of Hematologic Oncology
ISSN: 20451393
Publisher: Newlands Press Ltd
Journal Scope:

Current Climate Change Reports
ISSN:
Publisher: Springer International Publishing AG
Journal Scope: Atmospheric Science (Q1); Global and Planetary Change (Q1)

Current Obesity Reports
ISSN:
Publisher: Springer
Journal Scope: Internal Medicine (Q1)